SORT OUT X - Combo Stent Versus ORSIRO Stent
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 3140
Summary
- Conditions
- Angina Pectoris
- Coronary Heart Disease
- Myocardial Infarction
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Randomized Clinical Comparison of a Combined Sirolimus Eluting and endothelial progenitor cell COMBO Stent with a Sirolimus-eluting OSIRO stent in Patients Treated with Percutaneous Coronary Intervention.
Randomized Clinical Comparison of a Combined Sirolimus Eluting and endothelial progenitor cell COMBO Stent with a Sirolimus-eluting OSIRO stent in Patients Treated with Percutaneous Coronary Intervention.
Tracking Information
- NCT #
- NCT03216733
- Collaborators
- Biotronik SE & Co. KG
- OrbusNeich
- Investigators
- Principal Investigator: Lars Jakobsen, MD Aarhus University Hospital Skejby
Get Well Soon